Skip to Content

Align Technology Inc ALGN

Morningstar Rating
$308.04 +8.03 (2.68%)
View Full Chart
Unlock our analysis with Morningstar Investor

Company Report

Price vs Fair Value

ALGN is trading at a 3% discount.
Price
$308.08
Fair Value
$751.00
Uncertainty
High
1-Star Price
$177.40
5-Star Price
$618.20
Economic Moat
Rdjtfr
Capital Allocation
Yhyhkpcj

Bulls Say, Bears Say

Bulls

Invisalign is likely to win over new doctors and patients as adoption of clear aligners continues to increase and chips away wire and bracket’s market share.

Bears

Increasing competition in the clear aligner market could erode Invisalign’s market share over the long term.

Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if ALGN is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$300.01
Day Range
$299.41310.37
52-Week Range
$176.34413.20
Bid/Ask
$307.86 / $315.90
Market Cap
$23.59 Bil
Volume/Avg
614,852 / 1.0 Mil

Key Statistics

Price/Earnings (Normalized)
35.82
Price/Sales
6.11
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield
2.45%

Company Profile

Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the FDA in 1998, and it has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients’ teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans and iTero scans make up over half of these scans.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Mid Core
Total Number of Employees
21,610

Competitors

Valuation

Metric
ALGN
XRAY
STMN
Price/Earnings (Normalized)
35.8218.1850.24
Price/Book Value
6.372.14
Price/Sales
6.111.789.53
Price/Cash Flow
29.7215.1439.70
Price/Earnings
ALGN
XRAY
STMN

Financial Strength

Metric
ALGN
XRAY
STMN
Quick Ratio
0.980.761.34
Current Ratio
1.181.381.95
Interest Coverage
−1.1619.50
Quick Ratio
ALGN
XRAY
STMN

Profitability

Metric
ALGN
XRAY
STMN
Return on Assets (Normalized)
10.84%3.62%13.05%
Return on Equity (Normalized)
18.16%7.63%23.67%
Return on Invested Capital (Normalized)
17.22%5.75%18.17%
Return on Assets
ALGN
XRAY
STMN
See how this stock stacks up to its competitors with Morningstar Investor

Medical Devices Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
ABT
Abbott LaboratoriesKmkvk$208.3 Bil
SYK
Stryker CorpXctr$135.3 Bil
MDT
Medtronic PLCXvry$112.9 Bil
BSX
Boston Scientific CorpGjmpy$98.9 Bil
EW
Edwards Lifesciences CorpNgvth$52.3 Bil
DXCM
DexCom IncMrwz$47.1 Bil
ZBH
Zimmer Biomet Holdings IncKvfvp$25.7 Bil
PHG
Koninklijke Philips NV ADRZwqtqq$18.4 Bil
PODD
Insulet CorpXyhbn$11.7 Bil

Sponsor Center